Daniel Garcia

AlloVir, a clinical-stage developer of novel cell therapies, on its collaborations with Baylor College of Medicine, manufacturing agreements, clinical trial site negotiations, and other matters.

A private equity investment firm in the acquisition of a Mexican holdings company and its Latin American subsidiaries.*

A global supplier of technical textiles for the automotive industry in connection with the acquisition of a Texas-based corporation.

A Hong-Kong based company that operates in the financial services industry in connection with the acquisition of all of the equity interest held by a Texas-based limited liability company.

Bellicum Pharmaceuticals, a clinical-stage biopharmaceutical company in connection with the sale of a biomanufacturing facility.*

Caramelos Don Picoso, S.A. de C.V., a Mexico-based manufacturer and distributor of candy, on the negotiation of a Manufacturing Supply Agreement with a Texas-based entity.

Immatics, on its U.S. legal matters including collaboration with MD Anderson Cancer Center, licensing transactions, manufacturing, and clinical trial contracting, and other matters.

Plus Therapeutics, a clinical stage cancer company, in connection with clinical trial site negotiations, sponsored research, and other legal matters.

OncoResponse, a pre-clinical stage biotech company, in connection with the negotiation of manufacturing supply agreements and other corporate matters.**

Salarius Pharmaceuticals, a cancer-focused biotechnology company, on its strategic acquisition of certain assets from another company as well as various commercial agreements and corporate matters.

Several biotechnology companies on complex commercial agreements such as licensing, commercial and clinical supply, master services, collaboration, and clinical trial agreements.